Finished
Efficacy of End-Effector Robot-Assisted Gait Training in Subacute Stroke Patients
NCT03805009 · IRCCS San Raffaele Roma · Updated 10 April 2024
- What is being tested
- Robot-Assisted Gait Training (RAGT)
- For
- Severe Stroke; Acute Stroke; Mild Stroke; Central Nervous System Diseases; Cerebrovascular Disease; Brain Diseases; Cardiovascular Diseases; Gait, Hemiplegic
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 26 people. The full rules are on the registry page.
- Where
- Italy (2 sites)
- When
- Starts or started 19 March 2013, ends 30 Sept 2018. Registered 15 Jan 2019.
- Results
- None posted yet.
In the researchers' words
To date, no studies seems to compare conventional gait rehabilitation program with end-effector RAGT in subacute stroke patients by analysing the variations of gait kinematics beyond clinical multi prospective outcomes. The aim of this pilot study is to evaluate the efficacy of end-effector RAGT in subacute stroke patients in terms of clinical outcomes and gait kinematics, comparing them with conventional gait rehabilitation program.
Sites
- IRCCS San Raffaele PisanaRome, RM, Italy
- Fondazione Don Carlo Gnocchi OnlusRome, RM, Italy